RxDoctor Payments Data

Jennifer Baker, MD

Vascular Surgery · Flint, MINPI 1619233293

Payments from drug & device makers

$2,309in general payments, 2019–2025

Across 34 payments — averaging $67.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$2K
  • Progenacare Global, LLC$502
  • Medtronic$76
  • Cordis US CORP.$42
  • Boston Scientific$25
  • CSL Behring$20
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$2,28999%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
W. L. Gore & Associates, Inc.17$1,613
Progenacare Global, LLC8$502
Medtronic(2 entities)3$76
Cordis US CORP.2$42
Boston Scientific1$25
CSL Behring1$20
Smith+Nephew1$17
Shockwave Medical, Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,309 in reported general payments places this provider in the 35th percentile of 183 vascular surgery providers in Michigan.

See all vascular surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$282,892
Medicare patients
644
Services billed
3,559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$24,798
Atorvastatin Calcium37$569
ClopidogrelClopidogrel Bisulfate41$522

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →